KYMIRA’s® products were born in a research lab and continue to undergo scientific scrutiny and testing to this day.
What is KYnergy® Infrared Technology
Our KYnergy® Infrared embedded fabrics feature specially designed fibres which contain carefully selected natural minerals. These minerals are selected for their ability to absorb otherwise wasted energy from the wearer and surrounding light. The energy is then converted into a targeted region of the infrared light spectrum, which causes an array of positive biological effects. We target a specific area of infrared because of the very specific effects it has to aid, support and enhance human performance and recovery. Unlike other infrared technologies on the market, our technology is locked into the fibres and can never escape until the materials are recycled, the technology is built to last the life cycle of the garment. This means that our technology will never lose its effectiveness and will never fail you.
How KYnergy® Infrared Technology Works
Our KYnergy® Infrared technology absorbs the natural shorter wavelength, higher energy radiation that is given off by our own bodies and elements such as visible light in our natural surroundings, and the minerals in our fibres convert it into infrared light which is then emitted back into our bodies.For those that would like some atomic physics 101, this conversion occurs as the incoming photon causes excitation of the minerals at an atomic level. This is a less stable state for the atom, so it discharges the energy in the form of infrared light, within our targeted emission spectrum. This infrared will penetrate 4cm into your muscles and cause a peripheral effect of 2 – 3cm beyond that of the worn KYMIRA® product.
What Effects Does KYnergy® Infrared Technology Have on the Wearer
Nitric Oxide Production
When the body is exposed to infrared light it activates Endothelial Nitric Oxide Synthase, which is an enzyme found in our blood vessels. This converts L-Argenine into Nitric Oxide at a vastly accelerated rate in the areas of the body that our products cover. Nitric Oxide is a key component to many performance and recovery enhancing benefits, that are expanded on below. Compared to taking supplementation, KYMIRA’s® solutions will not cause systematic effects, and are more potent in areas of the body exposed to our KYnergy® fabric.
Temporarily increased Local Circulation
One of the primary effects of nitric oxide is vasodilation. This means it causes the blood vessels to expand, allowing more blood to pass through them. This has numerous benefits from increasing the volume of oxygen and nutrient rich blood to our muscle cells, to accelerating the rate at which waste products are transported away from them and reducing swelling during inflammatory responses. Significantly increased local circulation can be seen within 30 seconds of putting a KYMIRA® Sport product on. However, once the garments are removed, you will return to your baseline circulation, within 3 – 5 minutes. This biological excitement of red blood cells can be watched in our live video, presented by our Founder Tim Brownstone above, and we can demonstrate this to you personally in real time during meetings and at all exhibitions which we attend.
Increased Respiration Efficiency
The University of Calgary found that when wearing infrared clothing whilst exercising, athletes consumed less oxygen to achieve the same work output, measured in watts, indicating that the cells are working more efficiently.
Increased Tissue Oxygen Levels
In randomized double blind repeated measures studies, KYMIRA® products increased tissue oxygen levels by 20% on average compared against a host of control garments that used standard fabrics and/or compression. This increase was a building increase that both peaked and maintained after 70 minutes of wearing the KYMIRA® products.
There are a variety of pain relief responses that an athlete will experience when using our products. The first is an activation of the same chemical pathways that an opiate would activate (albeit less potently), when Nitric Oxide activates another chemical called Cyclic Guanosine Monophosphate (or cGMP for short). This process inhibits pain receptors and reduces pain while you are wearing KYMIRA® products. Once removed however, this pain inhibition will wear off as your body stops producing Nitric Oxide at such an accelerated rate. There are however, longer pain relief effects that are seen in athletes of all abilities when it comes to delayed onset muscle soreness (DOMS). Once our products are removed, DOMS does not return. Based on anecdotal evidence, which we are currently clinically testing, this is believed to be because exercising in KYMIRA® Sport products reduces the physiological causes of the DOMS itself*.
*Please note the pain relief statements only apply to KYMIRA® products that contain Celliant®. KYMIRA® products with Celliant® are Determined to be Medical Devices. The FDA has determined that products containing Celliant® are medical devices as defined in section 201(h) of the Federal Food, Drug and Cosmetic Act and are general wellness products. In the United States, the FDA has determined that Celliant® products are medical devices and are general wellness products. In Canada, the United Kingdom, the European Union, Australia, New Zealand and Japan, Celliant® is designated as a Class 1 Medical Device. Please note the pain relief statements only apply to Canada, the United Kingdom, the European Union, Australia, New Zealand and Japan
The chemical unit of energy that powers our cells is Adenosine Triphosphate (ATP). When you wear KYMIRA® Sport products, the infrared activates a molecule called Cytochrome C-Oxidase, a transmembrane protein in our mitochondria which mediates the production of ATP. Mitochondria are the power plants of our cells, where ATP is produced, and Cytochrome C-Oxidase is one of the gateways that allow workers through the power plant. By opening the gateway, ATP is production is increased and your cells have more fuel to carry out their functions.
Nitric Oxide has also been well documented to cause skeletal muscle tissue relaxation that enhances joint motion and muscle elasticity. This has wide reaching benefits from aiding recovery to reducing injury occurrence during training and competition. Elite athletes using KYMIRA® products for training and recovery, have reported an 80% reduction in injuries over a measured period, when compared to previously wearing standard clothing training kit.
KYMIRA® Sport products help to regulate temperature in a different way to standard clothing. This is due to some of the biological effects already described and some of the physical effects of the fabrics themselves. In colder climates, our fabrics warm up quicker, and then store the thermal energy 63% longer than an equivalent weight fabric would. In hotter climates however, they dry 65% quicker on average, dissipating excess heat through evaporation. Tying these two effects together is the increase in local circulation which allows your body to more efficiently transport heat around KYnergy® exposed areas, resulting in a regulating effect rather than just heating or cooling. Our customers wear KYMIRA® base layers in all-weather environments and the products have been used to great effect to regulate in temperatures ranging from -35 to +48 degrees (Celsius).
SPF and Antimicrobial
Our technology contains the mineral Quarts Dioxide. This is not included for infrared purposes, but rather its ability to absorb shorter wavelengths of UV light which is harmful to us. Once absorbed, it converts UV into a longer wavelength which is then more harmful to microbes. This dual effect gives our products a minimum rating of SPF 35 and an antimicrobial effect.
KYMIRA® Products with Celliant® are Determined to be Medical Devices
KYMIRA® products are safe to use and CE approved
The FDA has determined theat products containing Celliant® are medical devices as defined in section 201(h) of the federal Food, Drug and cosmetic Act and are general wellness products. In the United States, the FDA has determined that Celliant® products are medical devices and are general wellness productrs. In Canada, the United Kingdom, the European Union, Austrialia, New Zealand and Japan, Celliant® is designated as a Class 1 Device.
Hologenix’s peer-reviewed published studies:
Effect of Shirts with 42% Celliant® Fiber on tcPO2 Levels and Grip Strength in Healthy Subjects: A Placebo-Controlled Clinical Trial, Dr. Ian Gordon, Dr. Mark Vangel and Dr. Michael R Hamblin, Journal of Textile Science and Engineering, 2019.
Randomized Controlled Trial Comparing the Effects of Far-Infrared Emitting Ceramic Fabric Shirts and Control Polyester Shirts on Transcutaneous PO2, Dr. Ian Gordon, James Wason, Dr. Lawrence Lavery, Dr. Michael R Hamblin and MS Thein, Journal of Textile Science and Engineering, 2014.
Apparel with Far Infrared Radiation for Decreasing an Athlete’s Oxygen Consumption During Submaximal Exercise, Dr. Jay Worobets, Dr. Darren Stefanyshyn and Emma Skolnik, Research Journal of Textile and Apparel, 2011.
Effect of Optically Modified Polyethylene Terephthalate Fiber Socks on Chronic Foot Pain, Dr. Ian Gordon and Dr. Robyn York, BioMed Central Complementary & Alternative Medicine, 2009.
Infrared Radiative Properties and Thermal Modeling of Ceramic-Embedded Textile Fabrics, Dr. David Anderson, John Fessler, Matthew Pooley, Scott Seidel, Dr. Michael R Hamblin, Haskell Beckham and Dr. James F Brennan, Biomedical Optics Express, 2017.
Engineered Emissivity of Textile Fabrics by the Inclusion of Ceramic Particles, Dr. David M. Anderson, Matthew Pooley, Haskell W. Beckham and Dr. James F Brennan, Optics Express, 2016.
Far Infrared Radiation (FIR): Its Biological Effects and Medical Applications, Dr. Michael R Hamblin and Dr. Fatma Vatansever, Photonics and Lasers in Medicine, 2012.
Effect of Celliant® Materials on Pain and Strength in Subjects with Chronic Elbow and Wrist Pain, Dr. Ian Gordon and Dr. Michael R Hamblin, 2012.
The Test Report on the Impacts of Subject Socks with the Application of Celliant® Technical Fibers on Transcutaneous Oxygen Pressure on a Man’s Foot, Dr. Li Shaojing, Wu Chuanhong, Gao Jian, Zhu Li and Wen Liwei, 2012.
Transcutaneous Partial Pressure of Oxygen (tcPO2) as a Primary Endpoint to Assess the Efficacy of Celliant® as a Vasoactive Material, Dr. Ian Gordon and Dr. Michael Coyle, 2012.
Double Blind, Placebo Controlled, Crossover Trial on the Effect of Optically Modified Polyethylene Terephthalate Fiber Mattress Covers on Sleep Disturbances in Patients with Chronic Back Pain, Dr. Marcel Hungs and Dr. Annabel Wang, 2010.
Holofiber Study of Thirteen (13) Healthy Subjects for Tissue Oxygenation, Dr. Graham McClue, 2005.
Improving Blood Flow with Holofiber in the Hands and Feet of High-Risk Diabetics, Dr. Lawrence Lavery, 2003.
Full clinical texts are available on request.